Adult Dose of Guaifenesin (Mucinex)
The standard adult dose of guaifenesin is 200-400 mg every 4 hours (up to 6 times daily, maximum 2400 mg/day) for immediate-release formulations, or 600-1200 mg every 12 hours (maximum 2400 mg/day) for extended-release formulations. 1
Immediate-Release Formulations
- Dosing range: 200-400 mg orally every 4 hours 1
- Maximum frequency: Up to 6 times daily 1
- Maximum daily dose: 2400 mg 1
- The flexible dosing range allows titration to achieve adequate plasma concentrations based on symptom severity 1
- Multiple daily doses are required to maintain 24-hour therapeutic effect due to guaifenesin's short half-life 2
Extended-Release Formulations (Mucinex®)
- Standard dose: 600 mg (one tablet) every 12 hours 2
- Higher dose option: 1200 mg (two 600 mg tablets) every 12 hours for more severe symptoms 2, 3
- Maximum daily dose: 2400 mg 2
- Extended-release formulations provide bioequivalent steady-state exposure to immediate-release products while reducing dosing frequency 2
- The 1200 mg dose has been specifically studied and found well-tolerated in clinical trials 3, 4
Administration Considerations
- Food effects: Extended-release guaifenesin can be taken with or without food, though taking with food delays time to maximum concentration (Tmax) without affecting overall exposure 2
- Duration: Typically used for 7 days for acute upper respiratory tract infections 3, 4
- Tablet integrity: Extended-release tablets should be swallowed whole to maintain the controlled-release mechanism 2
Clinical Context
- Guaifenesin is indicated for relief of wet cough and chest congestion due to common cold and stable chronic bronchitis 1
- The drug acts as an expectorant by loosening mucus in airways and making coughs more productive 1
- Extended-release formulations offer convenience and improved compliance compared to immediate-release products requiring dosing every 4 hours 2
Safety Profile
- Guaifenesin has a well-established favorable safety profile in adults 1, 3
- In a post-marketing surveillance study of 552 adults taking 1200 mg every 12 hours for 7 days, all adverse events were mild in severity with no serious adverse events or deaths 3
- Most common adverse events include gastrointestinal symptoms, which are generally mild 3